Coyol, Costa Rica, September 25th, 2025. Freudenberg Medical, a global contract design and manufacturing (CDMO) partner to the medical device and biopharma industry, has officially inaugurated its second production facility in Costa Rica. The new site represents a $25 million investment to strengthen the company’s presence in one of the world’s most dynamic MedTech near-shoring hubs.
Freudenberg Medical opens second production facility in Costa Rica
$25 million investment. Expansion to quadruple manufacturing footprint. Leveraging VR and AI for seamless tech transfers and optimized factory layouts.
Keith Kiernan, Chief Commercial Officer | Robin Blair, Freudenberg Real Estate | Roger Gomez, General Manager Freudenberg Medical Costa Rica | Michael McGee, CEO Freudenberg Medical | Paula Guillen, Manager Supply Chain
"Costa Rica has become a cornerstone of our global operations over the past decade. With this new facility, we are expanding our capability to deliver high-quality, cost-effective medical technology solutions on a large scale, while staying close to our customers and supporting their long-term growth.”
Michael McGee,
CEO of Freudenberg Medical
The 50,000-square-foot facility is the company’s second site in the Coyol Free Zone. It is dedicated to the assembly of high-volume minimally invasive catheters for electrophysiology, vascular and structural heart therapies, and other medical devices that require precision manual assembly.
Three ISO 7 cleanrooms are operational from day one, with plans to double the site to 100,000 square feet within the next three years — quadrupling Freudenberg Medical’s total footprint in Costa Rica.
“This new facility underlines Freudenberg Medical’s confidence in Costa Rica as an integral part of our global growth strategy. In the next three years, we will grow our team from 350 to over 900 employees. Committed to diversity and inclusion, we offer equal opportunities to all, while providing meaningful careers in a growing industry that improves lives around the world.”
Róger Gómez,
VP and General Manager of
Freudenberg Medical Costa Rica
During 2025, the company’s existing 30,000-square-foot facility nearby will specialize in primary processing technologies, including precision molding and extrusion of thermoplastics for medical and biopharma applications, while assembly operations will be consolidated at the new site.
“Freudenberg Medical’s expansion in Costa Rica strengthens the country’s position as a strategic hub both regionally and globally. Today, more than 58,000 people are employed in this industry and exports surpassed USD 8.7 billion in 2024, growing on average 15% annually over the past 15 years. These figures reflect not only the trust that companies like Freudenberg place in our ecosystem, but also the ability of Costa Rican talent to drive complex advanced manufacturing processes with cutting-edge technologies such as artificial intelligence and virtual reality. At CINDE, we remain committed to supporting these investments that consolidate Costa Rica as a strategic partner for innovation and global health,”
Marianela Urgellés,
Managing Director of CINDE
Driving seamless tech transfers with VR and AI
The Costa Rica expansion is supported by advanced digital technologies. Freudenberg Medical combines Virtual Reality (VR) and Artificial Intelligence (AI) to enhance operator training, streamline production processes, and enable seamless technology transfers across its global vertically integrated network.
Operators train in immersive VR environments that replicate the exact conditions of the production floor, ensuring standardization in critical processes and consistent quality across all sites. At the same time, AI-powered layout planning is used to model and optimize production flows following lean principles – minimizing waste, reducing costs, and involving customers early in the planning of future production lines.
Press contact:
LAURA KIRSTEIN
Director of Marketing and CommunicationsMAURA LEAHY
Strategic Marketing Manager Minimally Invasive Solutions